Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mollisa M Elrick

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Basic & Clinical Pharmacology & Toxicology|April 26, 2006
Proteomics: recent applications and new technologiesMollisa M Elrick, Jennie L Walgren, Michael D Mitchell, et al.
American Journal of Physiology. Endocrinology and Metabolism|April 17, 2014
Neuronostatin inhibits glucose-stimulated insulin secretion via direct action on the pancreatic α-cellAlison S Salvatori, Mollisa M Elrick, Willis K Samson, et al.
Chemical Research in Toxicology|March 29, 2008
Peptide-based in vitro assay for the detection of reactive metabolitesMichael D Mitchell, Mollisa M Elrick, Jennie L Walgren, et al.
Experimental Biology and Medicine (Maywood, N.J.)|August 30, 2013
Synergistic effects of prostacyclin analogs and phosphodiesterase inhibitors on cyclic adenosine 3',5' monophosphate accumulation and adenosine 3'5' triphosphate release from human erythrocytesStephanie M Knebel, Mollisa M Elrick, Elizabeth A Bowles, et al.
Peptides|June 9, 2015
Understanding peptide biology: The discovery and characterization of the novel hormone, neuronostatinGina L C Yosten, Mollisa M Elrick, Alison Salvatori, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|November 13, 2015
Neuronostatin acts via GPR107 to increase cAMP-independent PKA phosphorylation and proglucagon mRNA accumulation in pancreatic α-cellsMollisa M Elrick, Willis K Samson, John A Corbett, et al.
Toxicologic Pathology|April 5, 2005
Differential display in rat livers treated for 13 weeks with phenobarbital implicates a role for metabolic and oxidative stress in nongenotoxic carcinogenicityMollisa M Elrick, Jeffrey A Kramer, Carl L Alden, et al.
Journal of Inflammation (London, England)|August 13, 2010
Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritisDebra M Meyer, Michael I Jesson, Xiong Li, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Basic & Clinical Pharmacology & Toxicology|April 26, 2006
Proteomics: recent applications and new technologiesMollisa M Elrick, Jennie L Walgren, Michael D Mitchell, et al.
American Journal of Physiology. Endocrinology and Metabolism|April 17, 2014
Neuronostatin inhibits glucose-stimulated insulin secretion via direct action on the pancreatic α-cellAlison S Salvatori, Mollisa M Elrick, Willis K Samson, et al.
Chemical Research in Toxicology|March 29, 2008
Peptide-based in vitro assay for the detection of reactive metabolitesMichael D Mitchell, Mollisa M Elrick, Jennie L Walgren, et al.
Experimental Biology and Medicine (Maywood, N.J.)|August 30, 2013
Synergistic effects of prostacyclin analogs and phosphodiesterase inhibitors on cyclic adenosine 3',5' monophosphate accumulation and adenosine 3'5' triphosphate release from human erythrocytesStephanie M Knebel, Mollisa M Elrick, Elizabeth A Bowles, et al.
Peptides|June 9, 2015
Understanding peptide biology: The discovery and characterization of the novel hormone, neuronostatinGina L C Yosten, Mollisa M Elrick, Alison Salvatori, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|November 13, 2015
Neuronostatin acts via GPR107 to increase cAMP-independent PKA phosphorylation and proglucagon mRNA accumulation in pancreatic α-cellsMollisa M Elrick, Willis K Samson, John A Corbett, et al.
Toxicologic Pathology|April 5, 2005
Differential display in rat livers treated for 13 weeks with phenobarbital implicates a role for metabolic and oxidative stress in nongenotoxic carcinogenicityMollisa M Elrick, Jeffrey A Kramer, Carl L Alden, et al.
Journal of Inflammation (London, England)|August 13, 2010
Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritisDebra M Meyer, Michael I Jesson, Xiong Li, et al.
Pageof 1